Liquid Crystal Nanoparticles Supercharge Antibiotics for Cystic Fibrosis – Insta News Hub
Mar 28 2024Reviewed by Lexie Nook Cystic fibrosis is the commonest, life-limiting genetic situation in Australia. It impacts the lungs, digestive system, and reproductive system, producing extra mucus, infections, and blockages. Now, due to a $ 500,000 grant from Brandon BioCatalyst’s CUREator incubator, by way of their CSIRO-funded Minimising Antimicrobial Resistance Stream, College of South Australia researchers are advancing the event of